NewsBenzingaDr Reddy's Laboratories Q2 EPS $0.12 Misses $0.16 Estimate, Sales $905.000M Miss $980.650M Estimate Dr Reddy's Laboratories Q2 EPS $0.12 Misses $0.16 Estimate, Sales $905.000M Miss $980.650M Estimate Benzinga 2026.10.23 12:27 (GMT+0) Open on Benzinga Other news 'NYSE Options Exchange Trading Halted By Technical Issue' - Bloomberg JP Morgan Maintains Neutral on Allegion, Raises Price Target to $183 JP Morgan Maintains Neutral on AGNC Investment, Raises Price Target to $8.5 StoneX Maintains Buy on Third Coast Bancshares, Lowers Price Target to $54 StoneX Maintains Buy on Pinnacle Finl Partners, Raises Price Target to $131 StoneX Maintains Buy on Boyd Gaming, Lowers Price Target to $80
